We are interested in the discovery of novel RNA binding peptides using in vitro selection. To do this, we use mRNA-protein fusions, peptides covalently attached to their encoding mRNA.
Introduction
There is great interest in creating peptides and proteins that bind nucleic acids with high affinity and specificity. In vitro and in vivo selection experiments are powerful techniques that provide functional solutions to nucleic acid recognition problems (1-5, and reviewed in 6). We have recently developed a novel strategy to perform in vitro peptide and protein selection using mRNA-protein fusions (mRNA display), proteins and peptides linked to their encoding mRNA (7, 8) . Under optimal conditions, synthesis of up to 100 trillion (10 14 ) independent sequences is possible, the largest peptide or protein library available with any system (9) .
In order to use mRNA display for the selection of RNA-binding peptides, we needed to design an efficient selection cycle. We have shown that the arginine-rich domain from the N protein retained the ability to bind its cognate boxBR target when synthesized as an mRNA-peptide fusion (9) . However, after fusion synthesis, there is great flexibility in both the number and order of the steps that can be incorporated into the selection cycle.
The key to a successful selection experiment is the enrichment of functional sequences from non-functional sequences. Affinity selection, reverse transcription, and PCR are the only essential steps in a selection cycle (boldface, Figure 3 .1). Other steps (e.g., affinity purification of the template, affinity purification of the peptide, a second affinity selection) may be added to improve the enrichment during the selection cycle.
Experimental design must balance the advantages of additional steps (lower background, higher stringency selection) with the disadvantages (decreased product yield, increased cycle time, PCR failure). A general goal is to achieve the maximum enrichment possible while still maintaining robust PCR after the selective step. An efficient selection cycle also maximizes the yield of product and reduces technical difficulties associated with multiple purification and enzymatic steps. Path used for selection cycle using the fusion system. The order of steps follows from top-to-bottom, and left-to-right. Steps that cannot be omitted are shown in bold.
We have systematically investigated a number of selection paths with the goal of developing a robust in vitro selection cycle for RNA-binding peptides. Our optimized cycle represents a facile approach to isolate novel peptides with high affinity and specificity. Our current protocol follows all the steps in (Figure 3 .1), from top to bottom and left to right. The methods we present should be generally applicable for the isolation of peptides and proteins that bind any immobilized target.
Results and Discussion

Fusion Synthesis
To begin a selection cycle, mRNA-peptide fusions must first be synthesized. The process has been described and optimized (7, 9) . Briefly, mRNA containing a 3' puromycin is translated in vitro at ~400 nM template concentration. Under these conditions, fusion synthesis is highly efficient and may be quantified in two ways: 1) the percent of the total synthesized peptide that is fused, or 2) the percent of input mRNA template that is converted to fusion product. After optimization, it is possible to convert up to 40% of the N template (Figure 3 .3a) and up to 50% of the N peptide to fusion product (Figure 3 .3b). 
Template-based Isolation
After translation and fusion formation, we isolate the input template from the translation reaction. Fusions are diluted into high salt buffer in the presence of dTcellulose or dT-agarose, which hybridizes to the poly-dA repeat present in the end of the input template. The resulting product consists of a mixture of mRNA-peptide fusions, a b
unfused template, and any puromycin linker present in the reaction. Template-based isolation has many advantages as the first purification step after translation. First, it is highly efficient, allowing recovery of up to 90% of the input template (both fused and unfused alike). Second, it allows the removal of the bulk of the protein present in the translation reaction, including unfused proteins and nucleases or proteases present in the lysate (see below). Finally, it is very gentle, requiring no denaturants that could unfold the peptide or protein component.
Peptide/Protein-based Isolation
After dT purification, the sample contains a mixture of fused and unfused templates. It is possible to proceed directly to the selective step provided that it is stringent enough to remove nonfunctional sequences. Removal of unfused template is especially critical if the fusion efficiency is relatively low (7); a large excess of unfused template gives a very high background, making selective enrichment of functional sequences challenging. Maximal enrichments will likely be garnered if the unfused template is removed first.
In the initial demonstration of the system, fused molecules were purified from unfused molecules via disulfide bond chromatography (7). We compared the efficiency of the original protocol with immunoprecipitation using the FLAG epitope tag (DYKDDDDK). Constructs were generated that contained the FLAG epitope as well as a single cysteine near the C-terminus of the peptide sequence. The results (Table 3 .1)
show that the peptides bind and elute much more efficiently from the thiopropyl sepharose support as compared to the anti-FLAG support. Overall, thiopropyl sepharose yields four times as much fusion material as does the FLAG affinity protocol, and was therefore incorporated into the selection cycle. Often, the buffer conditions or concentration of fusions at the end of one step need to be changed in order to prepare for the next step. We have used two approaches to exchange the buffer: ethanol precipitation and ultrafiltration. Fusions and libraries containing the N peptide can be efficiently precipitated and resuspended (~90% overall yield) using linear acrylamide as carrier (see Materials and Methods). Ultrafiltration using filters of appropriate molecular weight cutoff also give similar results (see Materials and Methods).
When to RT?
In principle, reverse transcription (RT) may be performed at almost any point in the selection cycle. In practice, the RT step should be performed after purification of the fusion from the lysate but before the selective step due to the following observations. the presence of RNaseH activity in the lysate (10) . Thus, the RNA portion of a cDNA/mRNA hybrid fusion will likely be degraded, destroying the physical linkage between the template and the peptide it encodes.
The efficiency of RT reactions depends on the amount of input template used.
Prior to the selective step, there is generally enough template present such that the RT reaction proceeds with high efficiency (J. E. Barrick, T.T. Takahashi, R.W. Roberts unpublished observations). After the selective step, the amount of mRNA present is often 100-fold less than in the previous steps. Low template concentrations (below the Km of the enzyme) can result in inefficient or failure of reverse transcription, causing the selection cycle to fail. Finally, synthesis of the cDNA/RNA hybrid removes RNA tertiary structures from the library, greatly decreasing the likelihood of isolating RNA aptamers rather than functional peptides and proteins.
The Selective Step-Enrichment using an RNA Target
We have shown that N peptide synthesized in reticulocyte lysate is functional and binds to its immobilized RNA target (boxBR) (9) . This peptide also showed a high degree of specificity in that it did not bind similar immobilized RNA structures, including the BIV-TAR site (11) and the HIV-RRE (12) . The peptide also retained its RNAbinding activity when generated as an mRNA-peptide fusion, making it an excellent candidate for selection experiments (9).
Our preliminary results from selection experiments highlight the importance of controlling the stringency and specificity of binding. Selection experiments using an N library indicate that the highest level of selective enrichment is attained when very large quantities of competitor are present in solution. Indeed, increasing the competitor (Yeast tRNA) concentration from 50 μg/mL to 5,000 μg/mL dramatically increases the efficiency of selection (13, Chapter 4). These results are consistent with those from the Pabo laboratory, where very large concentrations of competitor DNA were essential to isolate sequence specific zinc finger proteins (14) . Varying other biophysical parameters such as increasing the temperature and/or salt concentration would also be expected to increase the stringency of selection.
Conclusions
Several systems have been developed or applied to isolate peptides and proteins that bind RNA including 1) bacterial suppression analysis (15), 2) the yeast 3-hybrid system (1), 3) a bacterial antitermination system (2), 4) a mammalian cell transcriptional activation system (4), and 5) phage display selections (16) (17) (18) . In vivo systems have the advantage that they select for function in the context of cellular processes, whereas in vitro approaches provide access to larger libraries, reduced expression bias, and greater control over binding conditions.
In vitro selection using mRNA-peptide fusions presents a powerful addition to this list. Fusions containing the N peptide retain binding affinity and specificity to their cognate RNA (9, 13) . It is therefore likely that other arginine-rich peptides (such as BIVTat and HIV-Rev) or other RNA binding domains (such as zinc fingers or the RNP motif) may also serve as facile starting points for fusion-based selections. Large sequence complexities (up to 10 14 sequences, 10,000-fold more than phage display) are accessible with the fusion system, and should allow the discovery of rare functional sequences that could not be isolated with other systems. Finally, once isolated, functional sequences may be rapidly optimized by addition of in vitro recombination (19, 20) and mutagenesis (21) to the PCR portion of the selection cycle
Materials and Methods
Construction of Fusion Template
A double stranded DNA template encoding the 22 amino acid RNA-binding domain of phage N (underlined) (22) 
Translation and Fusion Formation
Fusion template was translated in reticulocyte lysate (Novagen) using conditions optimized for N peptide translation (400 nM template, 1.0 mM MgOAc, 100 mM KOAc). Upon completion of translation, fusion formation was stimulated by addition of 
Reverse Transcription
Reverse transcription with Superscript II RNAse H -Reverse Transcriptase (BRL, Life
Technologies) was according to the manufacturer's specifications. Addition of 2 to 10 equivalents of primer to template quantitatively generated cDNA-mRNA hybrid from the fusion template or fusion itself.
Splint Doping
N mRNA was generated using T7 runoff transcription in the presence of ( -32 P)-UTP (NEN) and ligated to the F30P oligonucleotide as described above. 0.02, 0.04, 0.2, 0.4, 2, 4, 20, and 40 pmol of splint were added to the reaction tubes and dried. Translation mixes were directly added to these tubes (as described above) and the products run on a 5% (stack)/15% (separating) tricine gel (24) and quantified by Phosphorimager (Molecular Dynamics).
Selective Step
Biotinylated boxBR hairpin (5'-GGCCCUGAAAAAGGGCCAAA-Biotin-3') was immobilized on streptavidin agarose (Pierce) pre-equilibrated in N binding buffer (10 mM HEPES pH 7.5, 100 mM KCl, 1 mM MgCl 2 , 0.5 mM EDTA, 1 mM DTT; 0.01% (v/v) NP-40) with 50, 500, or 5000 μg/mL of yeast tRNA (Boehringer Manheim).
cDNA/mRNA fusion was added to the binding reaction and incubated at 4 o C for 1 hour.
The agarose beads were washed three times with 1X binding buffer. Thirty microliters of ddH 2 O and 1 μL of RNaseA (Roche) were added and then incubated at 37 o C for 30 minutes to elute the bound fusions. One-tenth the volume of supernatant (~5 μL) was taken and 18 cycles of PCR performed to generate an enriched pool.
